Geode Capital Management’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.41M | Buy |
485,162
+149,595
| +45% | +$1.67M | ﹤0.01% | 2689 |
|
|
2025
Q1 | $4.12M | Buy |
335,567
+12,594
| +4% | +$155K | ﹤0.01% | 2742 |
|
|
2024
Q4 | $3.61M | Buy |
322,973
+5,781
| +2% | +$64.7K | ﹤0.01% | 2901 |
|
|
2024
Q3 | $2.21M | Buy |
317,192
+25,330
| +9% | +$177K | ﹤0.01% | 3088 |
|
|
2024
Q2 | $2.21M | Buy |
291,862
+174,902
| +150% | +$1.32M | ﹤0.01% | 3101 |
|
|
2024
Q1 | $1.54M | Buy |
116,960
+964
| +0.8% | +$12.7K | ﹤0.01% | 3213 |
|
|
2023
Q4 | $1.2M | Buy |
115,996
+5,787
| +5% | +$59.7K | ﹤0.01% | 3286 |
|
|
2023
Q3 | $1.07M | Buy |
110,209
+38,694
| +54% | +$377K | ﹤0.01% | 3287 |
|
|
2023
Q2 | $321K | Hold |
71,515
| – | – | ﹤0.01% | 3827 |
|
|
2023
Q1 | $332K | Hold |
71,515
| – | – | ﹤0.01% | 3811 |
|
|
2022
Q4 | $106K | Buy |
71,515
+5,945
| +9% | +$8.81K | ﹤0.01% | 4378 |
|
|
2022
Q3 | $245K | Hold |
65,570
| – | – | ﹤0.01% | 4087 |
|
|
2022
Q2 | $324K | Sell |
65,570
-51,298
| -44% | -$253K | ﹤0.01% | 3991 |
|
|
2022
Q1 | $959K | Sell |
116,868
-1,988
| -2% | -$16.3K | ﹤0.01% | 3638 |
|
|
2021
Q4 | $1.2M | Buy |
118,856
+896
| +0.8% | +$9.03K | ﹤0.01% | 3628 |
|
|
2021
Q3 | $1.87M | Buy |
117,960
+6,980
| +6% | +$111K | ﹤0.01% | 3376 |
|
|
2021
Q2 | $2.64M | Buy |
+110,980
| New | +$2.64M | ﹤0.01% | 3180 |
|